PLSE PULSE BIOSCIENCES INC revenue, earnings and financials
For the quarter ended June 30, 2026, PULSE BIOSCIENCES INC reported revenue of $434K, net income of −$24.7M and diluted EPS of n/a; over the last four quarters revenue was $1.19M and net income −$80.1M; for the fiscal year ended December 2025 revenue was $350K.
PLSE annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $350K, gross profit n/a, operating income −$76.9M, net income −$72.8M (margin -20794.6%), EPS n/a
- Fiscal year ended Dec 2024: revenue $0, gross profit n/a, operating income −$56.3M, net income −$53.6M (margin n/a), EPS n/a
- Fiscal year ended Dec 2023: revenue $0, gross profit n/a, operating income −$43.6M, net income −$42.2M (margin n/a), EPS n/a
- Fiscal year ended Dec 2022: revenue $700K, gross profit n/a, operating income −$58.1M, net income −$58.5M (margin -8357.9%), EPS n/a
- Fiscal year ended Dec 2021: revenue $1.42M, gross profit n/a, operating income −$63.0M, net income −$63.7M (margin -4489.4%), EPS −$2.28
PLSE quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $434K, net income −$24.7M, EPS n/a
- Quarter ended Mar 31, 2026: revenue $401K, net income −$18.6M, EPS n/a
- Quarter ended Dec 31, 2025 (from the annual report): revenue $264K, net income −$17.4M, EPS n/a
- Quarter ended Sep 30, 2025: revenue $86.0K, net income −$19.4M, EPS n/a
- Quarter ended Jun 30, 2025: revenue $0, net income −$19.2M, EPS n/a
- Quarter ended Mar 31, 2025: revenue $0, net income −$16.8M, EPS n/a
- Quarter ended Dec 31, 2024 (from the annual report): revenue $0, net income −$19.4M, EPS n/a
- Quarter ended Sep 30, 2024: revenue $0, net income −$12.7M, EPS n/a
- Quarter ended Jun 30, 2024: revenue $0, net income −$11.4M, EPS n/a
- Quarter ended Mar 31, 2024: revenue $0, net income −$10.1M, EPS n/a
- Quarter ended Dec 31, 2023 (from the annual report): revenue $0 (up 100.0% year over year), net income −$11.9M, EPS n/a
- Quarter ended Sep 30, 2023: revenue $0, net income −$10.6M, EPS n/a
- Quarter ended Jun 30, 2023: revenue $0 (down 100.0% year over year), net income −$9.91M, EPS n/a
- Quarter ended Mar 31, 2023: revenue $0 (down 100.0% year over year), net income −$9.80M, EPS n/a
- Quarter ended Dec 31, 2022 (from the annual report): revenue −$9.00K, net income −$9.20M, EPS n/a
- Quarter ended Sep 30, 2022: revenue $0 (down 100.0% year over year), net income −$18.0M, EPS −$0.49
- Quarter ended Jun 30, 2022: revenue $265K, net income −$14.0M, EPS −$0.44
- Quarter ended Mar 31, 2022: revenue $444K, net income −$17.3M, EPS −$0.58
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$15.4M, EPS −$0.51
- Quarter ended Sep 30, 2021: revenue $574K, net income −$14.3M, EPS −$0.48
PLSE cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$54.1M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$36.3M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$33.0M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$47.0M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$54.1M, share buybacks n/a
PLSE balance sheet
- Jun 30, 2026: cash $102M, total assets $116M, total liabilities $16.1M, shareholders' equity $99.5M
- Mar 31, 2026: cash $68.3M, total assets $81.6M, total liabilities $15.3M, shareholders' equity $66.3M
- Dec 31, 2025: cash $80.7M, total assets $94.5M, total liabilities $13.9M, shareholders' equity $80.7M
- Sep 30, 2025: cash $95.2M, total assets $109M, total liabilities $16.1M, shareholders' equity $92.7M
- Jun 30, 2025: cash $106M, total assets $120M, total liabilities $15.8M, shareholders' equity $104M
- Mar 31, 2025: cash $119M, total assets $133M, total liabilities $14.9M, shareholders' equity $118M
- Dec 31, 2024: cash $118M, total assets $132M, total liabilities $17.6M, shareholders' equity $115M
- Sep 30, 2024: cash $79.0M, total assets $93.0M, total liabilities $13.9M, shareholders' equity $79.1M
What is PLSE's revenue?
PULSE BIOSCIENCES INC reported $1.19M of revenue over its last four quarters, through June 30, 2026.
Is PLSE profitable?
No. PULSE BIOSCIENCES INC lost $80.1M over the last four quarters.